ZEPTISO Trademark

Trademark Overview

On Tuesday, July 19, 2016, a trademark application was filed for ZEPTISO with the United States Patent and Trademark Office. The USPTO has given the ZEPTISO trademark a serial number of 79193349. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 29, 2023. This trademark is owned by CROSSJECT. The ZEPTISO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, pharmaceutical preparations containing hydrocortisone for endocrinologic disorders
zeptiso

General Information

Serial Number79193349
Word MarkZEPTISO
Filing DateTuesday, July 19, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 29, 2023
Registration Number5220415
Registration DateTuesday, June 13, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations containing hydrocortisone for endocrinologic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCROSSJECT
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameCROSSJECT
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameCROSSJECT
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Friday, December 29, 2023CANCELLED SECTION 71
Monday, June 13, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, January 8, 2018LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 6, 2017LIMITATION OF GOODS RECEIVED FROM IB
Thursday, September 21, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 21, 2017FINAL DISPOSITION PROCESSED
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Saturday, March 25, 2017NOTIFICATION PROCESSED BY IB
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 8, 2017ASSIGNED TO LIE
Tuesday, January 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 18, 2016REFUSAL PROCESSED BY IB
Tuesday, November 1, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 1, 2016REFUSAL PROCESSED BY MPU
Tuesday, November 1, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 31, 2016NON-FINAL ACTION WRITTEN
Saturday, October 29, 2016ASSIGNED TO EXAMINER
Tuesday, October 18, 2016APPLICATION FILING RECEIPT MAILED
Friday, October 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 13, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, October 6, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zeptiso pharmaceutical endocrinologic disorders hydrocortisone preparations products namely containing